GSK is cutting staff, and a lot of it, reports Derek Lowe at In the Pipeline. "I'm hearing that the smallest cuts are around 40% of the entire research staff at the various sites,"  he writes. For those who have never been through a layoff, or are new to industry, Lowe wonders how much the "grass is greener" mentality will play into departing scientists' ideas of why they were let go.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.